Journal Mobile Options
Table of Contents
Vol. 72, No. 4, 1996
Issue release date: 1996
Add to my selection Citation Download
Cytogenet Cell Genet 1996;72:294–296
(DOI:10.1159/000134206)
Gene Mapping, Cloning, and Sequencing

Assignment of the human α-tropomyosin gene TPM4 to band 19p13.1 by fluorescence in situ hybridization

Wilton SD.a · Lim L.a · Dorosz S.D.a · Gunn H.C.a · Eyre H.J.b · Callen D.F.b · Laing N.G.a
aAustralian Neuromuscular Research Institute, QEII Medical Centre, Nedlands, Western Australia, andaCentre for Medical Genetics, Department of Cytogenetics and Molecular Genetics, Women’s and Children’s Hospital, Adelaide, South Australia (Australia) Cytogenet Cell Genet 1996;72:294–296 (DOI:10.1159/000134206)

Abstract

Sequence-tagged sites (STSs) were developed for the human α-tropomyosin gene TPM4. One STS was used to amplify DNA from somatic cell hybrids to localize TPM4 to chromosome 19. The other, a product from a long-range PCR, was used directly as a probe to refine the localization of TPM4 to 19p13.1 by fluorescence in situ hybridization to metaphase chromosome spreads.

 goto top of outline Author Contacts

Request reprints from Dr. S.D. Wilton, Australian Neuromuscular Research Institute, 4th Floor “A” Block, QE II Medical Centre, Nedlands, Western Australia 6009 (Australia); telephone: 61-9-346-3967; fax: 61-9-346-3487.


 goto top of outline Article Information

Received: 22 May 1995
Published online: May 16, 2008
Number of Print Pages : 3


 goto top of outline Publication Details

Cytogenetic and Genome Research

Vol. 72, No. 4, Year 1996 (Cover Date: 1996)

Journal Editor: Schmid M. (Würzburg)
ISSN: 1424–8581 (Print), eISSN: 1424–859X (Online)

For additional information: http://www.karger.com/CGR


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.